Analyst Price Target is $61.25
▲ +6.58% Upside Potential
This price target is based on 4 analysts offering 12 month price targets for National Health Investors in the last 3 months. The average price target is $61.25, with a high forecast of $64.00 and a low forecast of $58.00. The average price target represents a 6.58% upside from the last price of $57.47.
Current Consensus is
Hold
The current consensus among 4 contributing investment analysts is to hold stock in National Health Investors. This Hold consensus rating has held steady for over two years.
National Health Investors, Inc. engages in the sale-leaseback, joint-venture, mortgage, and mezzanine financing of senior housing and medical investments. Its portfolio includes lease, mortgage and other note investments in independent living facilities, assisted living facilities, entrance-fee communities, senior living campuses, skilled nursing facilities, specialty hospitals, and medical office buildings. The company was founded by W. Andrew Adams in 1991 and is headquartered in Murfreesboro, TN.
Read More